Business
Perimeter Medical Imaging AI to Report Second Quarter 2024 Financial Results and Host Conference Call on August 14, 2024
Perimeter Medical Imaging AI to Report Second Quarter 2024 Financial Results and Host Conference ...
About this update from Perimeter Medical Imaging Ai Inc
[{"type":"text","content":"\n\n\n\n Perimeter Medical Imaging AI to Report Second Quarter 2024 Financial Results and Host Conference Call on August 14, 2024\n \n\n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n\n\n\n\n\n Canada NewsWire\n \n\n\n\n\n\n TORONTO\n \n and\n \n DALLAS\n \n\n ,\n \n\n Aug. 7, 2024\n \n\n /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) (\"Perimeter\" or the \"Company\"), a commercial-stage medical technology company,  announced it will report its second quarter 2024 financial and operating results after market close on\n \n Wednesday, August 14, 2024\n \n . Following the announcement, Perimeter management will host a webcast and conference call to discuss the results and provide a corporate update.\n \n\n\n\n\n\n\n\n\n\n\n Second Quarter 2024 Results Conference Call Details:\n \n\n\n\n\n Date:\n \n\n Wednesday, August 14, 2024\n \n\n\n\n Time:\n \n\n 5:00 pm Eastern Time\n \n\n\n\n Dial-In Numbers:\n \n 1-800-717-1738 (\n \n Canada\n \n and\n \n the United States\n \n ) or 1-646-307-1865 (International)\n \n\n The call will also be broadcast live and archived on the\n \n\n Company's website\n \n\n under \"News/Events\" in the Investors section.\n \n\n\n About Perimeter Medical Imaging AI, Inc.\n \n\n Based in\n \n Toronto, Canada\n \n and\n \n Dallas, Texas\n \n ,\n \n\n Perimeter Medical Imaging AI\n \n\n (TSX-V: PINK) (OTC: PYNKF) (FSE: 4PC) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation artificial intelligence technology that is currently being evaluated in a pivotal clinical trial, with support from a grant of up to\n \n US$7.4 million\n \n awarded by the Cancer Prevention and Research Institute of\n \n Texas\n \n...